Quality-of-life in patients with long COVID: harnessing the scale of big data to quantify the health and economic costs

  • Funded by Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Total publications:30 publications

Grant number: COV-LT2-0073

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2023
  • Known Financial Commitments (USD)

    $947,128
  • Funder

    Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Principal Investigator

    N/A

  • Research Location

    United Kingdom
  • Lead Research Institution

    London School of Hygiene and Tropical Medicine
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    Digital Health

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Minority communities unspecifiedVulnerable populations unspecified

  • Occupations of Interest

    Unspecified

Abstract

We want to understand the impacts of long COVID on the quality-of-life of people who have developed this condition. For many health conditions, researchers ask people to fill in standardised surveys which measure quality-of-life, which help them understand how much the condition is affecting people. These kinds of measures are used in planning the resources for health systems, because they allow a standard way of comparing different health conditions, and, if people fill them in repeatedly, tracking changes in wellbeing over time. These quality-of-life measurements are not currently available for people with long COVID who did not need to be hospitalised during their COVID-19 episode. Our study aims to collect these measurements, by using a smartphone app linked to a patient s GP records. We will ask people to voluntarily participate in the study and use the app, and if they do so to give their consent for filling the questionnaires and for linkage to their health records. These results will tell us if long COVID has different quality-of-life impacts among different age groups, ethnicities, geographic regions, or because of any underlying health conditions. We will convert the results into standardised measurements that are used in the NHS to assess the impact of illnesses. This means they will be useful for working out how much the effects of long COVID cost the health service, and how we should prioritise interventions such as vaccines to avoid more people getting long COVID. Together with other researchers studying long COVID we will provide results to support long-term care. At all stages we will work with people affected by long COVID to ensure their input is central to designing the study plans and interpreting the outputs.

Publicationslinked via Europe PMC

Last Updated:41 minutes ago

View all publications at Europe PMC

Antibiotics for common infections in primary care before, during and after the COVID-19 pandemic: cohort study of extent of prescribing based on risks of infection-related hospital admissions.

Impact of COVID-19 on recorded blood pressure screening and hypertension management in England: an analysis of monthly changes in the quality and outcomes framework indicators in OpenSAFELY.

Changes in opioid prescribing during the COVID-19 pandemic in England: an interrupted time-series analysis in the OpenSAFELY-TTP cohort.

Changes in sick notes associated with COVID-19 from 2020 to 2022: a cohort study in 24 million primary care patients in OpenSAFELY-TPP.

OpenSAFELY: A platform for analysing electronic health records designed for reproducible research.

Incidence and treatment of group A streptococcal infections during covid-19 pandemic and 2022 outbreak: retrospective cohort study in England using OpenSAFELY-TPP.

OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.

Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data: validation study based on OpenSAFELY and UK Renal Registry.

OpenSAFELY: Measuring BMI in 22 million patients in England